Research Staff

Paul Bates

Senior Research Specialist

pdbates@pediatrics.wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4136

Monica Cho

Graduate Research Assistant

mcho54@wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4136

Matthew Forsberg, PhD

Postdoctoral Research Associate

mhforsberg@wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4136

Nicholas Mohrdieck

Student Researcher

nmohrdieck@wisc.edu

(847) 840-1410

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4137

Aicha Quamine

Graduate Research Assistant

quamine@wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4136

Sean Rinella, MPH

Graduate Research Assistant

srinella@wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4105

Longzhen Song, PhD

Postdoctoral Research Associate

lsong38@wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4136

Fernanda Szewc

Graduate Research Assistant

fmejia4@wisc.edu

(608) 265-2445

Hem/Onc & Bone Marrow Trans
Capitini Research Group
1111 Highland Ave, #4136

Research Group Alumni

 
Madeline Adam

Madeline was an undergraduate student at the University of Wisconsin-Madison majoring in Biology with a certificate in Business. She joined the Capitini Lab in September 2014 and her research involved optimizing therapies for graft-versus-host-disease after allogenic bone marrow transplant. Madeline graduated in May 2016 and is now an Associate Product Manager at Medline Industries.

 
Myriam N Bouchlaka, PhD

Myriam was in the Capitini lab from January 2012 – July 2016. Her translational research focused on developing fluorine-19 as a means of tracking human NK cells by MRI in vivo, inhibiting lymphoma growth with novel combinations of small molecule inhibitors, and on using macrophages to treat radiation-induced injury and GVHD. She was awarded the inaugural American Association of Immunologist’s Careers in Immunology Fellowship. After completing her postdoctoral fellowship, she obtained a position at Arch Oncology, an immuno-oncology company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers.”

UW Research Team Moves Cancer Immunotherapy Another Step Ahead

Cell Therapy Could Reduce Bone-Marrow Transplant, Radiation Injury Complications

 
Brittany Bowen

Brittany was an undergraduate student at the University of Wisconsin-Madison majoring in Human Development and Family Studies with an emphasis on Child Development. Her project involved optimizing NK cell infusions after allogeneic bone marrow transplant. Brittany graduated in May of 2015 and continued on to medical school to pursue a career in medicine, particularly pediatrics.

 
Dennis Ea

Dennis was a medical student at UW-Madison’s School of Medicine and Public Health. He graduated from Carleton College with a B.A. in Biology and concentration in Biochemistry in 2013. Dennis worked in the Capitini laboratory in Summer 2014. He was awarded a Pediatric Oncology Student Training award from Alex’s Lemonade Stand Foundation. His project examined the ability of BCL-2 inhibitors to inhibit T cell acute lymphoblastic leukemia (ALL) growth and survival both in vitro and in vivo. He also worked to determine if BCL-2 inhibition makes T cell ALL more amenable to immunotherapy by NK cells. After graduating medical school in 2017, Dennis enrolled in a Family Medicine Residency at St. Joseph’s Hospital in St. Paul, MN.

 
Thomas Esposito

Tom was an undergraduate at the University of Wisconsin-Madison majoring in Neurobiology and a certificate in Global Health Studies. Tom worked in the Capitini lab August 2012 – May 2014, and his research involved optimizing NK cell infusions after allogeneic bone marrow transplant. He graduated in May 2014 and enrolled in A.T Still University’s School of Osteopathic Medicine in Mesa, AZ.

 
Sarah FruchtmanSarah Fruchtman

Sarah was undergraduate student at University of Wisconsin-Madison majoring in Biology and Jewish Studies. She joined the Capitini lab in January 2019.

 
 
 
 
 
Tara Gavcovich

Tara graduated from Duke University with a BS in Psychology in 2014 and from George Washington University School of Medicine and Health Sciences in 2018. She worked for the Capitini Lab in Summer 2015 exploring usage of immunocytokines for neuroblastoma after allogeneic bone marrow transplant. She also studied combination therapies for T-ALL involving the JAK/STAT and Bcl-2 molecular pathways. Tara is now a Resident in Pediatrics at Holtz Children’s Hospital at University of Miami.

 
Katelyn Goodman

Katelyn was an undergraduate student at the University of Wisconsin-Madison majoring in Biology, graduating in May 2012. She worked in the Capitini Lab October 2011 – May 2012 studying GVHD and the graft-versus-leukemia response after allogeneic bone marrow transplant. After graduation, Katelyn obtained a job as a research technician at the University of Minnesota, where she is now in graduate school furthering her studies of GVHD.

 
Sabrina A. Kabakov

Sabrina was an undergraduate student at University of Wisconsin-Madison majoring in Nutritional science with a certificate in Global Health. She joined the Capitini Lab in August 2016 and focused on optimizing therapies for T-cell acute lymphoblastic leukemia through inhibiting the JAK/STAT and BCL2 pathways. She also worked with Miriam Kim developing novel cell therapies for GVHD. Sabrina graduated in May 2019 and planned to pursue a career in the medical field.

 
Sara Kelm

Sara was an undergraduate student at the University of Wisconsin-Madison majoring in Biology and Psychology. She worked in the Capitini Lab from June 2012 – May 2014, and was involved in optimizing NK cell infusions after allogeneic bone marrow transplant. She graduated in May 2014 and enrolled at the Medical College of Wisconsin in Milwaukee, WI.

 
Miriam Kim, DO

Miriam was a fellow in Pediatric Hematology/Oncology/BMT at the University of Wisconsin School of Medicine and Public Health. She did her Pediatrics residency at Advocate Children’s Hospital in Park Ridge, IL. Miriam was part of the Capitini Lab from July 2016 – June 2018, and her research focus was on developing alternatively activated macrophages for GVHD. Miriam was supported by a St. Baldrick’s Foundation Fellowship. After graduating fellowship in 2018, she went to the University of Minnesota for a specialized BMT fellowship.

 
Matthew Kutz

Matthew graduated from UW-Madison with a B.S. in Biology and Neurobiology in 2005. He worked in the Capitini lab as a medical student during the summer 2013 exploring trafficking of NK cells by 19F-MRI to neuroblastoma tumors. He was awarded a Summer Fellowship by the St. Baldrick’s Foundation. After graduating medical school in 2016, Matthew enrolled in an Anesthesiology Residency at the University of Washington Medical Center.

 
Michael Martinez

Michael was an undergraduate student majoring in Biomedical Engineering at the University of Wisconsin-Madison. He worked with the Capitini Lab from October 2011 – May 2015 as part of the Undergraduate Research Scholars program. His research involved the inhibition of the STAT-1 transcription factor as therapeutic treatment of pediatric hematological malignancies. Upon completion of his undergraduate studies, he obtained a job in Quality Assurance at Epic, Inc.

 
Sydney L. Olson

Sydney was an undergraduate student at the University of Wisconsin-Madison majoring in Biology with certificates in Global Health and Gender/Women’s Studies. She joined the Capitini Lab in June 2015 and her research involved treating neuroblastoma after allogeneic bone marrow transplant. She also optimized therapies for T-cell acute lymphoblastic leukemia by targeting the JAK/STAT pathway and BCL2 molecule. Sydney graduated in May 2018 and is working in the Ratner laboratory at Washington University in St. Louis.

 
Seema Rao, MD

Seema was a fellow in Pediatric Hematology/Oncology/BMT at the University of Wisconsin School of Medicine and Public Health. She did her Pediatrics residency at Children’s Hospital of Michigan and is board certified in Pediatrics. After residency, she worked as a General Pediatrician/urgent care physician. Seema was part of the Capitini Lab from August 2012 – June 2015, and her research focus was on targeting tumor-associated antigens of pediatric tumors using vaccines and immunotherapy after allogeneic BMT. Seema was supported by a T32 for Physician Scientist Training in Cancer Medicine. After graduating fellowship in 2015, she obtained a faculty position at Baylor College of Medicine/Texas Children’s Hospital.

 
Lauren Reil

Lauren was an undergraduate student at the University of Wisconsin-Madison majoring in Neurobiology. She worked the Capitini lab from January 2013 – May 2015, and her research involved the inhibition of the JAK1/STAT1 pathway as therapeutic treatment of pediatric hematologic malignancies. Lauren graduated in May 2015 and is now at Carroll University to become a Physician Assistant.

 
Erbay Salievski

Erbay was an undergraduate student at the University of Wisconsin-Madison studying Biology. He graduated in May of 2014 and pursued a career in medicine. Erbay was part of the Capitini Lab from January 2012 – May 2014, and his research involved the inhibition of the STAT-1 transcription factor as therapeutic treatment of pediatric hematological malignancies. After graduation, Erbay obtained a M.S. in Biomedical Sciences from Midwestern University and has been working at Adventist Hospital in La Grange, IL and Hinsdale, IL as a medical scribe and patient care assistant.

 
Kaitlyn Seibold

Kaitlyn was an undergraduate student at the University of Wisconsin-Madison majoring in Biology with a certificate in Business and Global Health. She joined the Capitini Lab in January 2016 and her research focused on optimizing therapies for T-cell acute lymphoblastic leukemia by targeting the BCL2 molecule and JAK/STAT signaling pathway. Kaitlyn graduated in May 2018 and planned to pursue a career in the medical field, preferably in pediatrics.

 
Keven J. Stonewall

Keven Stonewall was an undergraduate student at the University of Wisconsin-Madison majoring in Biology. He joined the Capitini Lab in September 2014 and his research involved optimizing NK cell infusions after allogeneic bone marrow transplant. Keven graduated in May 2017 and is now a medical student at Loyola University Chicago Stritch School of Medicine.

Learn More: UW-Madison sophomore Keven Stonewall develops vaccine to fight colon cancer, works to inspire through research

Q&A: Scholar-scientist Keven Stonewall is motivated by passion

Dream-catcher in a lab coat, UW biology student searches ways to cure cancer

 
Kyle Terry

Kyle was an undergraduate student at the University of Wisconsin-Madison majoring in Medical Microbiology & Immunology.  He joined the Capitini lab in June 2013 and used allogeneic bone marrow transplants (alloBMT) to optimize NK cell infusions for pediatric cancer. Kyle graduated in May 2016 and has been working as a medical scribe.


Katharine E. Tippins

Katharine was an undergraduate student at University of Wisconsin-Madison majoring in Neurobiology and Psychology. She joined the Capitini lab in Summer 2017 and studied how allogeneic bone marrow transplant can be used to treat osteosarcoma using NK cells. She graduated in May 2019 and planned pursue a career in the medical field. She was awarded a Summer Fellowship by the St. Baldrick’s Foundation.

 
Kaitlyn Voelz

Katie was an undergraduate student at the University of Wisconsin-Madison majoring in Human Development and Family Studies with an emphasis in Child Development. She worked in the Capitini Lab January 2012 – May 2012 studying the graft-versus-leukemia response after allogeneic bone marrow transplant. After graduation, Katie enrolled at the University of South Florida to pursue a M.S. In Medical Sciences. She was a medical student at St. George’s University from 2014-18, and is now a Resident in Pediatrics at University of Buffalo.

 
Kirsti WalkerKirsti Walker

Kirsti graduated from the University of Nevada, Reno in 2013 with a BS/MS in Biotechnology. There she focused on the interplay between cell death and axon guidance in Drosophila melanogaster. She joined the Capitini lab as a PhD candidate in November of 2014. Her research focused on investigating the role of the JAK/STAT signaling pathway and the anti-apoptotic molecule B-cell lymphoma 2 (BCL2) pathway in T-cell acute lymphoblastic leukemia (T-ALL). The project aimed at developing a novel combination therapy targeting both pathways.